Search

everythinglearnresearchcommunity

for

Search:↓

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Deleting Smad4 and PTEN genes in mice causes rapid, invasive forestomach cancer.

Suppressing very long chain fatty acids is linked to skin cancer.

Early balding may be a sign of future prostate problems.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

The PW91 method is best for calculating the basic physical and chemical properties of Finasteride, a drug used for prostate issues and hair loss.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

TGF-β signaling is crucial for stem cell maintenance, differentiation, and has implications for cancer treatment.

Lignans and neolignans from plants may help protect against various health issues, including cancer and heart disease.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

DHT in the human prostate is produced through multiple pathways, not just from testosterone.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Finasteride helps regrow hair and shrink prostate by reducing DHT, with some sexual side effects.

Finasteride may reduce prostate bleeding by lowering blood vessel growth factor levels and blood vessel density in certain prostate areas.

Finasteride helps treat hair loss and prostate enlargement by blocking a specific enzyme.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

Ursolic acid can shrink the prostate and lower a hormone linked to prostate growth in rats.

Finasteride reduces prostate bleeding by affecting blood vessel growth.

Cellular senescence has both cancer-blocking and cancer-promoting effects, and targeting senescent cells may improve health and lifespan.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Ozone therapy might improve cancer treatment and reduce its side effects.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Indian Gooseberry has potential for cancer prevention and treatment and promotes hair growth.